The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term follow-up of the PI3Kδ inhibitor TGR-1202 to demonstrate a differentiated safety profile and high response rates in CLL and NHL: Integrated-analysis of TGR-1202 monotherapy and combined with ublituximab.
 
Howard A. Burris
No Relationships to Disclose
 
Ian Flinn
Stock and Other Ownership Interests - RainTree Oncology Services
Research Funding - Acerta Pharma (Inst); Agios (Inst); Calithera Biosciences (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunogen (Inst); Incyte (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); Roche (Inst); Seagen (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst)
 
Matthew Alexander Lunning
Consulting or Advisory Role - Alexion Pharmaceuticals; Celgene; Genentech; Gilead Sciences; Juno Therapeutics; Spectrum Pharmaceuticals; TG Therapeutics
 
Julie Vose
Honoraria - Sanofi
Consulting or Advisory Role - Bio Connections
Research Funding - Acerta Pharma (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen Biotech (Inst); Kite, a Gilead company (Inst); Novartis (Inst); Pharmacyclics (Inst); Seagen (Inst); Spectrum Pharmaceuticals (Inst)
 
Nathan Hale Fowler
Consulting or Advisory Role - Pharmacyclics; TG Therapeutics
Research Funding - Pharmacyclics (Inst); Roche/Genentech (Inst); TG Therapeutics (Inst)
 
Loretta J. Nastoupil
Honoraria - Celgene; Genentech/Roche
Research Funding - Abbvie; Janssen Biotech; TG Therapeutics
Travel, Accommodations, Expenses - Janssen Biotech
 
Susan Mary O'Brien
Honoraria - Celgene; Gilead Sciences; Janssen; Pfizer; Pharmacyclics; ProNAi; Regeneron
Consulting or Advisory Role - Amgen; Celgene; CLL Global Research Foundation
Research Funding - Acerta Pharma; Gilead Sciences; Regeneron
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Janssen; Regeneron
 
Marshall T. Schreeder
Research Funding - TG Therapeutics (Inst)
 
Manish R. Patel
Honoraria - Gilead Sciences; Medivation; Taiho Pharmaceutical
Speakers' Bureau - Gilead Sciences; Medivation; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Gilead Sciences; Medivation; Taiho Pharmaceutical
 
Timothy Fenske
Consulting or Advisory Role - Celgene; Pharmacyclics (Inst); Seagen
 
Danielle M. Brander
Honoraria - Gilead Sciences
Research Funding - TG Therapeutics (Inst)
Travel, Accommodations, Expenses - MedImmune; ProNAi
 
Tanya Siddiqi
Speakers' Bureau - Janssen; Pharmacyclics; Seagen
 
Christopher Flowers
Consulting or Advisory Role - OptumRx; Seagen
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Gilead Sciences
 
Jan Andreas Burger
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Gilead Sciences; Infinity Pharmaceuticals; Janssen; Pharmacyclics
Research Funding - Celgene (Inst); Gilead Sciences (Inst); Pharmacyclics (Inst); Portola Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
William G. Wierda
Research Funding - TG Therapeutics (Inst)
 
John G. Kuhn
Consulting or Advisory Role - TG Therapeutics
 
Peter Sportelli
Employment - TG Therapeutics
Leadership - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Hari P. Miskin
Employment - TG Therapeutics
Leadership - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Michael S. Weiss
Employment - TG Therapeutics
Leadership - TG Therapeutics
Stock and Other Ownership Interests - TG Therapeutics
 
Owen A. O'Connor
Honoraria - Millennium; Mundipharma; Novartis; Seagen
Consulting or Advisory Role - Allos Therapeutics; Millennium; Mundipharma; Novartis; Seagen; Spectrum Pharmaceuticals
Research Funding - Acetylon Pharmaceuticals; Celgene; Millennium; Roche; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Acetylon Pharmaceuticals; Millennium; Mundipharma; Seagen; Spectrum Pharmaceuticals